All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.

The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
  TRANSLATE

The MDS Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MDS Hub cannot guarantee the accuracy of translated content. The MDS Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?

During the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the MDS Hub was pleased to speak to Nil Albiol, Hospital de la Santa Creu i Sant Pau, Barcelona, ES. We asked, Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?

Do mRNA-based COVID vaccines lead to adverse events in recently transplanted patients?

In this video, Albiol discusses the initial exclusion of transplanted patients from COVID vaccine trials due to the risk of immune-mediated complications. Albiol then comments on the study performed at his center and two other recently published studies, which did not find these side effects in transplanted patients. Finally, Albiol compares the overall results in transplanted patients to the general population.

 

More about...